Log In
Print
BCIQ
Print
Print this Print this
 

PRO 140

  Manage Alerts
Collapse Summary General Information
Company CytoDyn Inc.
DescriptionHumanized mAb against CC chemokine receptor 5 (CCR5; CD195)
Molecular Target CC chemokine receptor 5 (CCR5) (CD195)
Mechanism of ActionAntibody
Therapeutic ModalityBiologic: Antibody
Latest Stage of DevelopmentPhase II
Standard IndicationHIV / AIDS
Indication DetailsTreat HIV infection
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today